Safety of long-acting β-agonists

被引：12

作者：

Nelson, Harold S. ^{[1
]}

Dorinsky, Paul M.

机构：

[1] Natl Jewish Med & Res Ctr, Denver, CO 80206 USA

[2] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA

来源：

关键词：

D O I：

10.7326/0003-4819-145-9-200611070-00017

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：706 / 706

页数：1

共 50 条

[1] Safety of long-acting β-agonists uncertain
[J]. Reactions Weekly, 2006, 1086 (1) : 4 - 4
[2] Safety of long-acting β-agonists -: Response
Salpeter, Shelley R.
[J]. ANNALS OF INTERNAL MEDICINE, 2006, 145 (09) : 708 - 710
[3] Safety of long-acting β-agonists in asthma:: a review
Oppenheimer, John
Nelson, Harold S.
[J]. CURRENT OPINION IN PULMONARY MEDICINE, 2008, 14 (01) : 64 - 69
[4] Safety of Long-Acting Beta-Agonists in Asthma
Knox, Samantha M.
Schroer, Brian C.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (02): : 750 - 751
[5] Safety and efficacy of long-acting beta-agonists
Gawlowska, Marta
Pawliczak, Rafal
[J]. ALERGIA ASTMA IMMUNOLOGIA, 2007, 12 (03): : 142 - 154
[6] Safety Trials of Long-Acting β2-Agonists
Weinberger, Miles
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (15): : 1481 - 1482
[7] Safety of long-acting beta-agonists - Reply
Martinez, FD
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (11): : 1207 - 1208
[8] Safety of long-acting β2-agonists in asthma
de Benedictis, Fernando Maria
Carloni, Ines
[J]. THORAX, 2012, 67 (11) : 1014 - U110
[9] Safety in the use of long-acting β2 agonists in asthma
Solnor, Ludvik Saxhaug
Skeie, Oystein Stenerud
Spigset, Olav
Slordal, Lars
[J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2019, 139 (17) : 1666 - 1670
[10] Safety of long-acting β2-agonists in asthma
Rishton, Louise
[J]. LANCET RESPIRATORY MEDICINE, 2016, 4 (11): : 860 - 860